Thomas Hedner and Jean Lycke 2019. CRISPR/Cas9 system and gene editing tools: On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine. Stockholm Intellectual Property Law Review . 2, 1 (Jun. 2019), 12–23. DOI:https://doi.org/10.59625/siplr.v2i1.63298.